SG Americas Securities LLC Has $101,000 Stock Position in Health Catalyst, Inc. (NASDAQ:HCAT)

SG Americas Securities LLC cut its stake in shares of Health Catalyst, Inc. (NASDAQ:HCAT) by 33.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 10,858 shares of the company’s stock after selling 5,473 shares during the period. SG Americas Securities LLC’s holdings in Health Catalyst were worth $101,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of HCAT. Bank of New York Mellon Corp raised its position in Health Catalyst by 124.0% in the third quarter. Bank of New York Mellon Corp now owns 854,896 shares of the company’s stock valued at $8,652,000 after purchasing an additional 473,323 shares during the last quarter. Vanguard Group Inc. boosted its position in Health Catalyst by 1.2% during the 3rd quarter. Vanguard Group Inc. now owns 6,441,707 shares of the company’s stock worth $65,190,000 after buying an additional 78,823 shares during the period. MQS Management LLC bought a new stake in Health Catalyst during the 3rd quarter worth approximately $116,000. American Century Companies Inc. increased its position in Health Catalyst by 10.4% in the 3rd quarter. American Century Companies Inc. now owns 657,552 shares of the company’s stock valued at $6,654,000 after acquiring an additional 62,010 shares during the period. Finally, Shell Asset Management Co. bought a new position in shares of Health Catalyst during the third quarter valued at $195,000. 85.00% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

HCAT has been the subject of a number of recent research reports. Barclays started coverage on Health Catalyst in a report on Wednesday, January 3rd. They issued an “overweight” rating and a $14.00 price objective for the company. KeyCorp reaffirmed a “sector weight” rating on shares of Health Catalyst in a research note on Wednesday, April 10th. Cantor Fitzgerald reissued an “overweight” rating and set a $16.00 target price on shares of Health Catalyst in a research report on Wednesday, April 10th. Evercore ISI lowered their price target on shares of Health Catalyst from $11.00 to $10.00 and set an “outperform” rating for the company in a report on Friday, February 23rd. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $15.00 price objective (down from $17.00) on shares of Health Catalyst in a research note on Friday, February 23rd. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $12.10.

Health Catalyst Price Performance

Shares of NASDAQ HCAT opened at $5.58 on Friday. The company has a current ratio of 4.42, a quick ratio of 4.42 and a debt-to-equity ratio of 0.62. The firm’s 50-day moving average price is $7.80 and its 200-day moving average price is $8.41. The firm has a market capitalization of $326.76 million, a P/E ratio of -2.66 and a beta of 1.29. Health Catalyst, Inc. has a 1-year low of $5.51 and a 1-year high of $14.37.

Health Catalyst (NASDAQ:HCAT) last posted its quarterly earnings results on Thursday, February 22nd. The company reported ($0.21) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.06. Health Catalyst had a negative return on equity of 12.19% and a negative net margin of 39.92%. The business had revenue of $75.08 million for the quarter, compared to the consensus estimate of $73.67 million. Equities research analysts anticipate that Health Catalyst, Inc. will post -0.47 earnings per share for the current fiscal year.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.